Publications by authors named "John Woolley"

Claim this Profile
T
The Healthy Aging Initiative (HAI): an interdisciplinary longitudinal cohort study to characterize and promote healthspan in senior housing.
Yael Koren, On-Yee Lo, Davide Balos Cappon, Maggie Syme, Heather Andrews, John Woolley

Front Public Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity.
Paul T Kennedy, Emma L Saulters, Andrew D Duckworth, Yeong Jer Lim, John F Woolley

Mol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers.
Emma L Saulters, Paul T Kennedy, Rachel J Carter, Abdullah Alsufyani, Terence M Jones, John F Woolley

Cancer Res Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroblastoma: an ongoing cold front for cancer immunotherapy.
Paul T Kennedy, Demetra Zannoupa, Meong Hi Son, Lekh N Dahal, John F Woolley

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML.
Martino Marco Gabra, Jonathan Tak-Sum Chow, Taehyung Kim, Meong Hi Son, Andrea Arruda, John F Woolley

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worked to the bone: antibody-based conditioning as the future of transplant biology.
James M Griffin, Fiona M Healy, Lekh N Dahal, Yngvar Floisand, John F Woolley

J Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Progress in Interferon Therapy for Myeloid Malignancies.
Fiona M Healy, Lekh N Dahal, Jack R E Jones, Yngvar Floisand, John F Woolley

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STINGing Viral Tumors: What We Know from Head and Neck Cancers.
Emma Saulters, John F Woolley, Shankar Varadarajan, Terence M Jones, Lekh N Dahal

Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Old Dog, New Trick: Type I IFN-Based Treatment for Acute Myeloid Leukemia.
Abdullah Alsufyani, Rehab Alanazi, John F Woolley, Lekh N Dahal

Mol Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Damage/Repair Management in Cancers.
Jehad F Alhmoud, John F Woolley, Ala-Eddin Al Moustafa, Mohammed Imad Malki

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
Irakli Dzneladze, John F Woolley, Carla Rossell, Youqi Han, Ayesha Rashid

PLoS One· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of PTEN by Flow Cytometry.
John F Woolley, Leonardo Salmena

Methods Mol Biol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A universal preconditioner for simulating condensed phase materials.
David Packwood, James Kermode, Letif Mones, Noam Bernstein, John Woolley

J Chem Phys· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
John F Woolley, Irakli Dzneladze, Leonardo Salmena

Trends Mol Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells.
Joanna Stanicka, Eileen G Russell, John F Woolley, Thomas G Cotter

J Biol Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox-regulated growth factor survival signaling.
John F Woolley, Aoife Corcoran, Gillian Groeger, William D Landry, Thomas G Cotter

Antioxid Redox Signal· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1.
D Peter O'Leary, Lavinia Bhatt, John F Woolley, David R Gough, Jiang H Wang

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H2O2 production downstream of FLT3 is mediated by p22phox in the endoplasmic reticulum and is required for STAT5 signalling.
John F Woolley, Ruth Naughton, Joanna Stanicka, David R Gough, Lavinia Bhatt

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib and Nilotinib inhibit Bcr-Abl-induced ROS through targeted degradation of the NADPH oxidase subunit p22phox.
William D Landry, John F Woolley, Thomas G Cotter

Leuk Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The isolation and identification of a secreted biomarker associated with cell stress in serum-free CHO cell culture.
John F Woolley, Mohamed Al-Rubeai

Biotechnol Bioeng· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of SELDI-TOF mass spectrometry to mammalian cell culture.
John F Woolley, Mohamed Al-Rubeai

Biotechnol Adv· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of an Integrated Care Pathway for all patients with advanced life-limiting illness - the Supportive Care Pathway.
Jill Main, Claire Whittle, Jonathan Treml, John Woolley, Alistair Main

J Nurs Manag· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis